Managers
Hedge funds, including Tudor Investment Corp and Hunting Hill Capital, significantly increased their exposure to US bitcoin exchange-traded funds in Q4 2024, capitalising on the cryptocurrency’s 47% surge, according to newly released regulatory filings.
Point72 Asset Management, the hedge fund firm founded by Steve Cohen, has increased its investment in Sphere Entertainment, upping its stake to 7.3% as the company grapples with ongoing debt restructuring negotiations tied to its MSG Networks subsidiary, according to a report by Sportico.
Matthews International has announced a series of corporate governance changes in response to mounting pressure from activist hedge fund Barington Capital Group, as a heated proxy battle nears its conclusion, according to a report by Reuters.
The Dubai International Financial Centre (DIFC) has reported a record-breaking 25% increase in company registrations last year, with the surge in part being driven by a wave of hedge funds, including Dymon Asia and JJJ Capital, setting up operations in the city, according to a report by Bloomberg.
Hedge funds with bearish positions on the Australian dollar are facing potential losses as the currency shows resilience despite negative market sentiment, according to a report by Bloomberg citing RBC Capital Markets and Westpac Banking Corp.
Sydney-based hedge fund startup Minotaur Capital, which has replaced traditional analysts with artificial intelligence, has beaten the global stock market in its first six months while significantly reducing research costs, according to a report by Bloomberg.
Bridgewater Associates, the world’s largest hedge fund, increased its stake in Tesla during the fourth quarter while trimming exposure to the so-called “Magnificent Seven” tech stocks, according to a report by Reuters, citing the firm’s latest regulatory filing.
Viking Global, the $45.3bn long-short hedge fund led by Andreas Halvorsen, become the latest hedge fund to increase its position in Boeing in Q4, acquiring a new $526m stake in aerospace giant, according to a report Reuters, citing recent regulatory filings.
Citadel, the multi-strategy hedge fund major founded by Ken Griffin, has taken a £305m ($384.5m) short position in GSK, which equates to 0.515 of the British pharmaceutical giant’s stock, according to a report by the Financial Times.
Kaifeng Investment Management, a macro hedge fund that posted an impressive 76% gain last year, believes the market is underestimating the potential for significant US interest rate cuts in 2026, according to a report by Bloomberg.
